What is Fulcrum Therapeutics Inc (FULC) stock price today?

Fulcrum Therapeutics Inc (FULC) currently trades at $7.15 per share. The stock has a market capitalization of $522.15M and a P/E ratio of —x.

Is FULC stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Fulcrum Therapeutics Inc has a Smart Value Score of 34/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

FULC

Fulcrum Therapeutics Inc

NASDAQ: FULC · HEALTHCARE · BIOTECHNOLOGY

$7.15

-3.90% today

Updated 2026-04-29

Market cap

$522.15M

P/E ratio

—

P/S ratio

2.66x

EPS (TTM)

$-1.18

Dividend yield

—

52W range

$4 – $16

Volume

1.2M

Market cap

$522.15M

P/E ratio

—

P/S ratio

2.66x

EPS (TTM)

$-1.18

Dividend yield

—

52W range

$4 – $16

Volume

1.2M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.7

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$19.00

+165.73%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy6 Buy1 Hold0 Sell1 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-18.76M

- Revenue declining -100.00% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$6.34M	$2.81M	$80.00M	$0.00	$0.00
Net income	$-109.87M	$-97.33M	$-9.72M	$-74.88M	$-18.89M
EPS	—	—	—	—	$-1.18
Free cash flow	$-99.01M	$-91.47M	$-2.50M	$-60.38M	$-18.76M
Profit margin	-1,732.43%	-3,470.05%	-12.16%	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-02-02	TOURANGEAU, GREG	Buy	57,000	—
2026-02-02	SAPIR, ALEX	Buy	650,000	—
2026-02-02	OLTMANS, CURTIS GALE	Buy	170,000	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
FULC	$522.15M	34	3.7	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Fulcrum Therapeutics Inc trades at $7.15. Our Smart Value Score of 34/100 indicates the stock is weak.

Frequently asked questions

What is Fulcrum Therapeutics Inc's stock price?

Fulcrum Therapeutics Inc (FULC) trades at $7.15.

Is Fulcrum Therapeutics Inc overvalued?

Smart Value Score 34/100 (Grade F, Strong Sell).

What is the price target of Fulcrum Therapeutics Inc (FULC)?

The analyst target price is $19.00, representing +165.7% upside from the current price of $7.15.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio2.66x

ROE-25.30%

Beta3.27

50D MA$8.17

200D MA$8.85

Shares out0.07B

Float0.04B

Short ratio—

Avg volume1.2M

Performance

1 week-0.39%

1 month+17.33%

3 months-26.34%

YTD-31.74%

1 year—

3 years—

5 years—

Compare

FULC vs LLY →FULC vs JNJ →FULC vs ABBV →Stock screener →